Public Employees Retirement System of Ohio Boosts Holdings in Astera Labs, Inc. $ALAB

Public Employees Retirement System of Ohio grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 30.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 44,459 shares of the company’s stock after purchasing an additional 10,492 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Astera Labs were worth $4,020,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Oliver Lagore Vanvalin Investment Group purchased a new position in shares of Astera Labs in the second quarter valued at approximately $29,000. GAMMA Investing LLC lifted its stake in Astera Labs by 55.7% in the first quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock worth $47,000 after acquiring an additional 284 shares during the last quarter. Sound Income Strategies LLC lifted its stake in Astera Labs by 34.7% in the first quarter. Sound Income Strategies LLC now owns 792 shares of the company’s stock worth $47,000 after acquiring an additional 204 shares during the last quarter. Harbour Investments Inc. lifted its stake in Astera Labs by 351.7% in the first quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock worth $47,000 after acquiring an additional 619 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. purchased a new position in Astera Labs in the first quarter worth approximately $48,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Astera Labs from a “hold” rating to a “buy” rating in a research note on Saturday, August 16th. Jefferies Financial Group lifted their price target on shares of Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, July 22nd. Cowen assumed coverage on shares of Astera Labs in a research note on Tuesday. They issued a “hold” rating for the company. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price target for the company. in a research note on Tuesday, July 22nd. Finally, Morgan Stanley lifted their price target on shares of Astera Labs from $155.00 to $200.00 and gave the stock an “overweight” rating in a research note on Friday, August 29th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $152.94.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $195.80 on Wednesday. The firm’s fifty day simple moving average is $185.00 and its 200-day simple moving average is $116.75. The stock has a market capitalization of $32.55 billion, a price-to-earnings ratio of 349.64, a PEG ratio of 5.04 and a beta of 1.48. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to analysts’ expectations of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company’s quarterly revenue was up 149.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the sale, the director directly owned 385,863 shares in the company, valued at approximately $66,858,482.01. The trade was a 32.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jack R. Lazar sold 22,500 shares of the business’s stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the completion of the sale, the director owned 97,351 shares in the company, valued at $17,369,365.42. This represents a 18.77% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,513,027 shares of company stock worth $233,510,161. 12.50% of the stock is currently owned by insiders.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.